Thyroid cancer is the most common endocrine malignancy, although representing fewer than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary and follicular histotypes and their variants, accounting for more than 90% of all thyroid cancers. Given the changing presentation of DTC in the last years, the aim of DTC management is to ensure the most effective but least invasive treatment, and adequate follow-up for a disease that nowadays is mostly cured just with surgery and is rarely fatal. This review addresses the multiple steps of current management, based on previous assumptions.
|Titolo:||Approach to and treatment of differentiated thyroid carcinoma|
|Citazione:||Pacini, F., & Castagna, M.G. (2012). Approach to and treatment of differentiated thyroid carcinoma. THE MEDICAL CLINICS OF NORTH AMERICA, 96(2), 369-383.|
|Appare nelle tipologie:||1.1 Articolo in rivista|